STOCKWATCH
·
Major Chemicals
Quarterly ResultMay 6, 2026, 04:39 PM

Ingevity Q1 Adjusted EPS $1.15; Net Sales Up 4% to $258M

AI Summary

Ingevity Corporation reported first quarter 2026 net sales of $258.0 million, a 4% increase year-over-year. Net income from continuing operations was $23.4 million ($0.65 diluted EPS), down from $29.1 million ($0.79 diluted EPS) in the prior year, primarily due to a $16.2 million litigation charge. Adjusted earnings from continuing operations rose to $41.4 million ($1.15 adjusted diluted EPS), while adjusted EBITDA was $91.5 million, flat year-over-year. The company completed two divestitures for a total of $158 million and repurchased $52 million in shares, reaffirming its full-year guidance.

Key Highlights

  • Net sales increased 4% to $258.0 million in Q1 2026.
  • Net income from continuing operations was $23.4 million ($0.65 diluted EPS).
  • Adjusted diluted EPS from continuing operations rose to $1.15.
  • Adjusted EBITDA from continuing operations was $91.5 million, flat year-over-year.
  • Performance Materials sales grew 6% to $155.4 million, with segment EBITDA up 10% to $92.0 million.
  • Completed two divestitures for approximately $158 million ($93M for Industrial Specialties, $65M for Road Markings).
  • Repurchased $52 million in common stock during the first quarter.
  • Reaffirmed full-year 2026 guidance for net sales ($1.05B-$1.15B) and adjusted EBITDA ($370M-$395M).
NGVT
Major Chemicals
Ingevity Corp

Price Impact